NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Sell
33
ADAG Quote, Financials, Valuation and Earnings
Last price:
$1.88
Seasonality move
:
20.76%
Day range:
$1.89 - $2.07
52-week range:
$1.60 - $4.38
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.96x
P/B ratio:
1.60x
Volume:
36.8K
Avg. volume:
85.5K
1-year change:
13.33%
Market cap:
$90.3M
Revenue:
$18.1M
EPS (TTM):
-$0.73
Analysts' Opinion
-
Consensus RatingAdagene has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Adagene has an estimated upside of 293.51% from its current price of $2.04.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $2.04.
Fair Value
-
According to the consensus of 0 analysts, Adagene has 293.51% upside to fair value with a price target of -- per share.
ADAG vs. S&P 500
-
Over the past 5 trading days, Adagene has overperformed the S&P 500 by 1.04% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Adagene does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Adagene has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Adagene reported revenues of --.
Earnings Growth
-
Adagene has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Adagene reported earnings per share of --.
Enterprise value:
15.2M
EV / Invested capital:
--
Price / LTM sales:
4.96x
EV / EBIT:
--
EV / Revenue:
0.84x
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2019-12-31 | 2020-12-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | $480K | $391.4K | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -$5.4M | -$12.4M | |
| EBITDA | -- | -- | -- | -$4.4M | -$12.5M | |
| Diluted EPS | -- | -- | -- | -$0.14 | -$0.31 | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $215.2M | $175M | $132.7M | $98.8M | |
| Total Assets | -- | $217.9M | $178.6M | $135.3M | $100.8M | |
| Current Liabilities | -- | $29.6M | $56.5M | $39M | $39.5M | |
| Total Liabilities | -- | $31.6M | $65.9M | $52.5M | $44.2M | |
| Total Equity | -- | $186.2M | $112.7M | $82.8M | $56.6M | |
| Total Debt | -- | $7.7M | $16.6M | $24.9M | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2018-09-30 | 2019-09-30 | 2020-09-30 | 2019-09-30 | 2020-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -$11.8M | -$20M | |
| Cash From Investing | -- | -- | -- | $18.9M | $7.4M | |
| Cash From Financing | -- | -- | -- | $16.3M | $3.1M | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
ADAG
Sector
Market Cap
$90.3M
$43.9M
Price % of 52-Week High
46.58%
45.73%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
13.33%
-29.11%
Beta (5-Year)
--
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$2.06
200-day SMA
Sell
Level
$2.59
Bollinger Bands (100)
Sell
Level
2.15 - 2.85
Chaikin Money Flow
Buy
Level
226K
20-day SMA
Sell
Level
$2.17
Relative Strength Index (RSI14)
Sell
Level
43.20
ADX Line
Sell
Level
13.52
Williams %R
Neutral
Level
-79.1667
50-day SMA
Sell
Level
$2.45
MACD (12, 26)
Sell
Level
-0.11
25-day Aroon Oscillator
Buy
Level
4
On Balance Volume
Neutral
Level
427.2K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-1.682)
Sell
CA Score
(Annual)
Level (-0.6204)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (2.5603)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.
Stock Forecast FAQ
In the current month, ADAG has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ADAG average analyst price target in the past 3 months is --.
-
Where Will Adagene Stock Be In 1 Year?
According to analysts, the consensus estimate is that Adagene share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Adagene?
Analysts are divided on their view about Adagene share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Adagene is a Sell and believe this share price will drop from its current level to --.
-
What Is Adagene's Price Target?
The price target for Adagene over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ADAG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Adagene is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ADAG?
You can purchase shares of Adagene via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Adagene shares.
-
What Is The Adagene Share Price Today?
Adagene was last trading at $1.88 per share. This represents the most recent stock quote for Adagene. Yesterday, Adagene closed at $2.04 per share.
-
How To Buy Adagene Stock Online?
In order to purchase Adagene stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is down 2.5% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 3% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 5.85% over the past day.
